IXC invex therapeutics ltd

Good level of detail and provides clarity around the basis for...

  1. 145 Posts.
    lightbulb Created with Sketch. 46
    Good level of detail and provides clarity around the basis for the decisions made and the path forward. Seems like the major shareholders are active and management is sound. 28c per share cash backing provides some level of safety (although some of it will need to be spent closing out the existing trial, and on admin and running costs, as well as pursuing the other opportunities outlined). Comfortable holding at these levels to see how this plays out.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
9.0¢
Change
0.002(2.27%)
Mkt cap ! $6.763M
Open High Low Value Volume
8.8¢ 9.0¢ 8.8¢ $8.48K 95K

Buyers (Bids)

No. Vol. Price($)
1 42086 8.3¢
 

Sellers (Offers)

Price($) Vol. No.
9.7¢ 9000 1
View Market Depth
Last trade - 11.50am 18/07/2025 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.